Docoh
Loading...

MRVI Maravai LifeSciences

News

From Benzinga Pro
Codex DNA Announces Commercial Availability Of Automated mRNA Synthesis Kit With Integrated Capping Technology For BioXp System
29 Nov 21
News
Codex DNA, Inc. (NASDAQ:DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the commercial launch of its BioXp™ mRNA synthesis kits with CleanCap® Reagent AG, a proprietary mRNA
56 Biggest Movers From Friday
29 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
48 Stocks Moving In Friday's Mid-Day Session
26 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded higher amid concerns of a new COVID variant discovered in South Africa.
Maravai LifeSciences Q3 EPS $0.44 Beats $0.35 Estimate, Sales $204.81M Beat $201.50M Estimate
10 Nov 21
Earnings, News
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.35 by 25.71 percent. The company reported quarterly sales of $204.81 million which beat
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
10 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For November 10, 2021
10 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Maravai LifeSciences Holdings Says New England Biolabs Releases Next Generation HiScribe In Vitro Transcription Kit, Incorporating TriLink Biotechnologies' CleanCap Technology For mRNA Synthesis
8 Nov 21
News, FDA
New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
8 Nov 21
Biotech, Earnings, News, Penny Stocks, Small Cap, IPOs, Top Stories, General
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week.
92 Biggest Movers From Friday
8 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Maravai LifeSciences Announced New European Patent
7 Oct 21
News
Maravai LifeSciences, Inc. (NASDAQ: MRVI) announced today that the European Patent Office has issued a new patent, No. 3352584, to the company's TriLink BioTechnologies subsidiary.
54 Biggest Movers From Friday
4 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
60 Biggest Movers From Friday
13 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
41 Stocks Moving In Friday's Mid-Day Session
10 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Friday's Pre-Market Session
10 Sep 21
Pre-Market Outlook, Markets, Movers
20 Stocks Moving in Friday's Pre-Market Session
10 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
8 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)
Maravai LifeSciences Announces Launch Of Proposed Secondary Offering Of 20M Shares Of Class A Common Stock
7 Sep 21
News, Offerings
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering
Maravai Offloads Vector Labs To Private Equity
7 Sep 21
M&A, News, Health Care, Asset Sales, General

Press releases

From Benzinga Pro
Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System
29 Nov 21
News, Press Releases, General
Proven CleanCap® reagent technology from TriLink BioTechnologies delivers significant time and cost savings for mRNA-based vaccine and therapeutic applicationsCodex DNA scientists to share latest data and showcase
New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis
8 Nov 21
Press Releases
IPSWICH, Mass., Nov. 8, 2021 /PRNewswire/ -- New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
13 Oct 21
News, Press Releases
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its
Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
7 Oct 21
News, Health Care, Legal, Press Releases
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the European
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
4 Oct 21
Health Care, Press Releases
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- TriLink BioTechnologies ("TriLink"), a Maravai LifeSciences company (NASDAQ:MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
10 Sep 21
Health Care, Markets, Press Releases
SAN DIEGO, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
7 Sep 21
Markets, Press Releases
SAN DIEGO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today
Thompson Street Capital Partners Acquires Vector Laboratories
7 Sep 21
Press Releases
Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced it has acquired Vector Laboratories, the Protein Detection business unit of Maravai (NASDAQ:MRVI). Vector Laboratories is a